Identification of a novel CBFB-MYH11 transcript: implications for RT–PCR diagnosis

2001 ◽  
Vol 2 (3) ◽  
pp. 206-209 ◽  
Author(s):  
Bert A Van der Reijden ◽  
Linda de Wit ◽  
Sonja van der Poel ◽  
Erna B Luiten ◽  
Marina Lafage-Pochitaloff ◽  
...  
Keyword(s):  
Rt Pcr ◽  
Pcr Diagnosis

scholarly journals CLINICAL PROPERTIES AND DIAGNOSTIC METHODS OF COVID-19 INFECTION IN PREGNANCIES: META-ANALYSIS

2020 ◽  
Author(s):  
Banu Uygun-Can ◽  
Bilge Acar-Bolat
Keyword(s):  
Pregnant Women ◽  
Clinical Features ◽  
Retrospective Studies ◽  
Clinical Symptoms ◽  
Meta Analysis ◽  
Diagnostic Methods ◽  
Imaging Features ◽  
Medical Evidence ◽  
Rt Pcr ◽  
Pcr Diagnosis

AbstractWe aimed to summarize reliable medical evidence by the meta-analysis of all published retrospective studies that examined data based on the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by clinical symptoms, molecular (RT-PCR) diagnosis and characteristic CT imaging features in pregnant women. MEDLINE PubMed, SCOPUS, ISI Web of Science, Clinical Key, and CINAHL databases were used to select the studies. Then, 384 articles were received, including the studies until 01/MAY/2020. As a result of the full-text evaluation, 12 retrospective articles covering all the data related were selected. A total of 181 pregnant cases with SARS-CoV-2 infections were included in the meta-analysis within the scope of these articles. According to the results, the incidence of fever was 38.1% (95% CI: 14.2–65%), and cough was 22% (95% CI: 10.8–35.2%) among all clinical features of pregnant cases with SARS-CoV-2 infection. So, fever and cough are the most common symptoms in pregnant cases with SARS-CoV- infection, and 91.8% (95% CI: 76.7–99.9%) of RT-PCR results are positive. Moreover, abnormal CT incidence is 97.9% (95% CI: 94.2–99.9%) positive. No case was death. However, as this virus spreads globally, it should not be overlooked that the incidence will increase in pregnant women and may be in the risky group. RT-PCR and CT can be used together in an accurate and safe diagnosis. In conclusion, these findings will provide important guidance for current studies regarding the clinical features and correct detection of SARS-CoV-2 infection in pregnant women, as well as whether it will create emergency tables that will require the use of a viral drug.

RT-PCR diagnosis of recurrent rearrangements in pediatric acute lymphoblastic leukemia in Argentina

2012 ◽  
Vol 36 (6) ◽  
pp. 704-708 ◽  
Author(s):  
Cristina N. Alonso ◽  
Marta S. Gallego ◽  
Jorge G. Rossi ◽  
Adriana Medina ◽  
Patricia L. Rubio ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Lymphoblastic Leukemia ◽  
Rt Pcr ◽  
Pediatric Acute Lymphoblastic Leukemia ◽  
Pcr Diagnosis

Unknown primary cancer (UPC): Accuracy of tissue of origin prediction by molecular profiling

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 11070-11070
Author(s):  
F. A. Greco ◽  
D. R. Spigel ◽  
D. A. Yardley ◽  
M. Erlander ◽  
X. Ma ◽  
...  
Keyword(s):  
Molecular Profiling ◽  
Primary Site ◽  
Unknown Primary ◽  
Rt Pcr ◽  
Pcr Assay ◽  
Arch Pathol ◽  
Pcr Diagnosis ◽  
Formalin Fixed Paraffin ◽  
Diagnostic Biopsy ◽  
Formalin Fixed Paraffin Embedded

11070 Background: Molecular profiling may be useful to identify the primary site and direct therapy for patients (pts) with UPC. Since most UPC pts never have a primary site identified, the accuracy of molecular profiling diagnoses are difficult to verify. We identified a group of UPC pts who had a primary site subsequently identified during their clinical course, and performed a 92-gene real time polymerase chain reaction (RT-PCR) assay (Arch Pathol Lab Med 130:465, 2006) on tissue from the initial diagnostic biopsy. We then compared the RT-PCR diagnosis with the subsequent clinical diagnosis. Methods: 38 of 501 UPC pts (7%) seen between 2000 and 2008 had their primary tumor subsequently identified during life. 24 of the 38 pts had tissue biopsies (excluding FNA cytology) and are the subject of this study. The RT-PCR assay was performed on unstained slides from the formalin-fixed, paraffin-embedded (FFPE) initial diagnostic biopsy, and the assay predictions were compared to the actual primary sites (found later). No clinical or pathologic data (other than sex, biopsy site, and 1 H&E stained slide) were used in the prediction of the primary site. Results: 16 of 24 assays were successful (8 had no tumor or RNA in the material). 11 of 16 predictions of the site of origin (68%) were correct, corresponding to the actual primary sites found 3–58 months (median 8.5 months) after the initial diagnosis of UPC. Primary sites correctly identified included breast 2, ovary/peritoneal 4, NSCLC 1, colorectal 2, gastric 1, melanoma 1. 3 predictions were inaccurate (colorectal, testicular, sarcoma) in patients with gastroesophageal, pancreas and NSCLC, respectively. 2 assays were unclassifiable. Conclusions: RT-PCR performed on FFPE initial diagnostic tissue was accurate in predicting the primary site of origin in 11 of 16 pts with UPC who eventually had their primary site identified clinically. These data provide a direct validation of the reliability of this RT-PCR assay in predicting the primary site in pts with UPC. When used in concert with clinical features and IHC stains, molecular profiling may provide the basis for more successful site-directed therapy for many of these pts. Prospective studies of RT-PCR in UPC are ongoing. [Table: see text]

scholarly journals Assessment of humoral responses in COVID-19 using various quantitative antibody tests

2021 ◽  
pp. 000456322110067
Author(s):  
Masatoshi Wakui ◽  
Yoshifumi Uwamino ◽  
Toshinobu Kurafuji ◽  
Masayo Noguchi ◽  
Akemi Ohno ◽  
...  
Keyword(s):  
Diagnostic Performance ◽  
Herd Immunity ◽  
Antibody Responses ◽  
Rt Pcr ◽  
Pcr Diagnosis ◽  
Antibody Titres ◽  
Measurement Principle ◽  
Time Courses ◽  
Humoral Responses ◽  
Antibody Tests

Background Quantitative antibody tests are expected to be useful in diagnostics of COVID-19 and investigation of herd immunity against SARS-CoV-2. To make it proper to perform them, understanding of the immunological aspects is critically important. The present study aimed to assess humoral responses in COVID-19 using various quantitative antibody tests. Methods Four quantitative antibody tests that are different in targeted antigens, detectable immunoglobulin classes and avidity were used. Diagnosis was confirmed by RT-PCR for SARS-CoV-2 detection. Antibody titres of 117 samples collected from 24 COVID-19 patients and 23 non-COVID-19 patients were measured to evaluate correlations between different tests. For 24 COVID-19 patients, antibody titres measured at various time points after the onset or the RT-PCR diagnosis were subjected to assessment of humoral responses. Results Correlations between tests were observed to some degree, although there were discrepancies putatively due to differences in measurement principle. Seronegative COVID-19 was diagnosed for some patients, in whom antibody titres were less than the cut-off value in each test throughout the time courses. IgG seroconversion without prior IgM seroconversion most frequently occurred, while predominance of IgM responses over IgG responses was observed in some severe cases. Viral burdens estimated according to threshold cycle values at the RT-PCR seemed to impact antibody responses. Conclusions The results provide insights into the nature of humoral responses to SARS-CoV-2 and diagnostic performance of antibody tests.

scholarly journals Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Rapid Living Review

2021 ◽  
Author(s):  
Katherine Mackey ◽  
Irina Arkhipova-Jenkins ◽  
Charlotte Armstrong ◽  
Emily Gean ◽  
Johanna Anderson ◽  
...  
Keyword(s):  
Antibody Response ◽  
Symptom Onset ◽  
Neutralizing Antibodies ◽  
Severe Disease ◽  
Patient Characteristics ◽  
Immunoglobulin M ◽  
Rt Pcr ◽  
Antibody Prevalence ◽  
Pcr Diagnosis ◽  
Almost All

 Evidence suggests that the majority of adults develop detectable levels of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies following infection with SARS-CoV-2 (moderate strength of evidence* [SoE]).  IgM levels peak approximately 20 days after symptom onset or RT-PCR diagnosis and subsequently decline. IgG levels peak approximately 25 days after symptom onset or RT-PCR diagnosis and may remain detectable for at least 120 days (moderate SoE*).  Almost all adults develop neutralizing antibodies in response to SARS-CoV-2 infection, and these antibodies may remain detectable for at least 152 days (low SoE*).  A small percentage of people do not develop antibodies in response to SARS-CoV-2 infection for reasons that are largely unclear but may be related to less severe disease or absence of symptoms.  Antibody prevalence does not appear to vary by age or sex, but older age may be associated with higher antibody levels (low SoE*). Non-White race may be associated with higher antibody prevalence and levels (low SoE*). COVID-19 severity and presence of symptoms may also be associated with higher antibody prevalence or levels (low SoE*). More evidence is needed to draw stronger conclusions regarding how the antibody response varies by patient characteristics and disease factors.  Studies to date have not established the relationship between the development of antibodies after RT-PCR-diagnosed SARS-CoV-2 infection and the risk of reinfection. Studies based on index serologic testing suggest that the presence of antibodies is associated with a lower risk of a subsequent positive SARS-CoV-2 RT-PCR test.

scholarly journals Assessment of a Diagnostic Strategy Based on Chest Computed Tomography in Patients Hospitalized for COVID-19 Pneumonia: an observational study

2020 ◽  
Author(s):  
Marine Thieux ◽  
Anne-Charlotte Kalenderian ◽  
Aurélie Chabrol ◽  
Laurent Gendt ◽  
Emma Giraudier ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Observational Study ◽  
Sensitivity And Specificity ◽  
Chest Ct ◽  
Time Interval ◽  
Diagnostic Strategy ◽  
Rt Pcr ◽  
Chest Computed Tomography ◽  
Pcr Diagnosis ◽  
Significant Difference

AbstractObjectivesTo assess the relevance of a diagnostic strategy for COVID-19 based on chest computed tomography (CT) in patients with hospitalization criteria.SettingObservational study with retrospective analysis in a French emergency department (ED).Participants and interventionFrom March 3 to April 2, 2020, 385 adult patients presenting to the ED for suspected COVID-19 underwent an evaluation that included history, physical examination, blood tests, real-time reverse transcription-polymerase chain reaction (RT-PCR) and chest CT. When the time-interval between chest CT and RT-PCR assays was longer than 7 days, patients were excluded from the study. Only patients with hospitalization criteria were included. Diagnosis accuracy was assessed using the sensitivity and specificity of RT-PCR.OutcomesSensitivity and specificity of RT-PCR, chest CT (also accompanied by lymphopenia) were measured and were also analyzed by subgroups of age and sex.ResultsAmong 377 included subjects, RT-PCR was positive in 36%, while chest CT was compatible with a COVID-19 diagnosis in 59%. In the population with positive RT-PCR, there were more men (55% vs 37%, p=0.015), a higher frequency of reticular and, or, interlobular septal thickening (53% vs 31%, p=0.02) as well as a higher frequency of bilateral lesion distribution (98% vs 86%, p=0.01) compared to the population with negative RT-PCR. The proportion of lymphopenia was higher in men vs women (47% vs 39%, p=0.03) and varies between patients >80 versus 50-80 and p<0.001).Using CT as reference, RT-PCR obtained a sensitivity of 61%, specificity of 93%. There was a significant difference between CT and RT-PCR diagnosis performance (p<0.001). When CT was accompanied by lymphopenia, sensitivity and specificity of RT-PCR were respectively 71% and 94%. CT abnormalities and lymphopenia provided diagnosis in 29% of patients with negative PCR.ConclusionsChest CT had a superior yield than RT-PCR in COVID-19 hospitalized patients, especially when accompanied by lymphopenia.

RT-PCR: Diagnosis value in dogs with spontaneous acute-, subacute-, and chronic-demyelinating distemper encephalitis

2009 ◽  
Vol 128 (1-3) ◽  
pp. 343
Author(s):  
Edson M. Scarpelli ◽  
Karime C. Scarpelli ◽  
Alexandre M. Amude ◽  
Amauri A. Alfieri ◽  
Maria L. Cintra
Keyword(s):  
Rt Pcr ◽  
Pcr Diagnosis
Sign in / Sign up

Export Citation Format

Share Document